SCHEMBL259180

SCHEMBL259180

NCC(=O)N(CC(=O)O)C(=O)C(N)Cc1c[nH]cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9555934 0.89 SLC1A1 (0.36)
SCHEMBL9748876 0.84 GSR (0.37)
SCHEMBL2078990 0.82 GSR (0.35)
SCHEMBL30121454 0.81 NLN (0.33)
SCHEMBL11028922 0.79 CYP1A2 (0.32)
SCHEMBL7586770 0.79 CYP3A4 (0.30)
Histidine SCHEMBL2763245 0.78 SLC7A5 (0.43)
Histidine SCHEMBL8027991 0.78 SLC7A5 (0.43)
Histidine SCHEMBL1801721 0.78 SLC7A5 (0.43)
Histidine SCHEMBL1136528 0.78 SLC7A5 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8865857-B2 Medical device with predefined activated cellular integration SOFRADIM PRODUCTION (FR) 2014-10-21 US claimed
US-4732155-A Implantable chemoattractant system THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 1988-03-22 US claimed
US-9586989-B1 Non-toxic skin cancer therapy with copper peptides SKIN BIOLOGY, INC. (US) 2017-03-07 US disclosed
US-8865857-B2 Medical device with predefined activated cellular integration SOFRADIM PRODUCTION (FR) 2014-10-21 US disclosed
US-20130143976-A1 MEDICAL DEVICE WITH PREDEFINED ACTIVATED CELLULAR INTEGRATION SOFRADIM PRODUCTION (FR) 2013-06-06 US disclosed
EP-2588153-A2 MEDICAL DEVICE WITH PREDEFINED ACTIVATED CELLULAR INTEGRATION Sofradim Production (FR) 2013-05-08 EP disclosed
WO-2012001532-A2 MEDICAL DEVICE WITH PREDEFINED ACTIVATED CELLULAR INTEGRATION SOFRADIM PRODUCTION (FR) 2012-01-05 WO disclosed
EP-0438600-B2 ENZYMES WHICH PARTICIPATE IN C-TERMINAL AMIDATION, AND PRODUCTION AND USE THEREOF SHISEIDO CO LTD (JP) 2002-10-09 EP disclosed
US-6156555-A Method of preparing an enzyme participating in C-terminal amidation SHISEIDO COMPANY LTD. (JP) 2000-12-05 US disclosed
EP-0666318-B1 Enzyme participating in c-terminal amidation, and method of preparing same and use thereof SHISEIDO CO LTD (JP) 2000-11-29 EP disclosed
US-5871995-A Purified enzymes participating in C-terminal amidation SHISEIDO COMPANY, LTD. (JP) 1999-02-16 US disclosed
EP-0438600-B1 ENZYMES WHICH PARTICIPATE IN C-TERMINAL AMIDATION, AND PRODUCTION AND USE THEREOF SHISEIDO CO LTD (JP) 1996-02-07 EP disclosed
EP-0666318-A1 Enzyme participating in c-terminal amidation, and method of preparing same and use thereof SHISEIDO COMPANY LIMITED (JP) 1995-08-09 EP disclosed
US-5354675-A Amidation of glycine SHISEIDO COMPANY LTD. (JP) 1994-10-11 US disclosed
EP-0447547-B1 C-TERMINUS AMIDATION ENZYME COMPOSITION, PROCESS FOR ITS PREPARATION AND ITS USE SHISEIDO CO LTD (JP) 1994-07-27 EP disclosed
US-5252559-A A stimulate mixture of a tripeptides and carrier THE PROCTER & GAMBLE COMPANY (US) 1993-10-12 US disclosed
US-5252559-A A stimulate mixture of a tripeptides and carrier THE PROCTER & GAMBLE COMPANY (US) 1993-10-12 US disclosed
EP-0447547-A1 C-TERMINUS AMIDATION ENZYME COMPOSITION, PROCESS FOR ITS PREPARATION AND ITS USE SHISEIDO COMPANY LIMITED (JP) 1991-09-25 EP disclosed
EP-0438600-A1 ENZYMES WHICH PARTICIPATE IN C-TERMINAL AMIDATION, AND PRODUCTION AND USE THEREOF SHISEIDO COMPANY LIMITED (JP) 1991-07-31 EP disclosed
US-4732155-A Implantable chemoattractant system THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 1988-03-22 US disclosed